[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100609517":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":12,"centralContacts":16,"locations":21,"responsibleParty":39,"collaborators":7,"id":41,"slug":42,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":45,"acronym":7,"eligibilityCriteria":46,"healthyVolunteers":43,"sex":47,"minAge":7,"maxAge":7,"enrollmentInfo":48,"targetDuration":7,"studyType":51,"phases":7,"briefSummary":52,"conditions":53,"keywords":7,"overallStatus":24,"whyStopped":7,"lastUpdateSubmitDate":56,"lastUpdatePostDateStruct":57,"startDateStruct":60,"completionDateStruct":62,"leadSponsor":64,"locationsCount":65},{"fullName":5,"class":6},"M.D. Anderson Cancer Center","OTHER",null,[9],{"type":6,"name":10,"description":11,"armGroupLabels":7,"otherNames":7},"data collection","data collection from electronic health records",[13],{"name":14,"affiliation":5,"role":15},"Shalin S Patel, MD","PRINCIPAL_INVESTIGATOR",[17],{"name":14,"role":18,"phone":19,"phoneExt":7,"email":20},"CONTACT","713-792-6268","sspatel@mdanderson.org",[22],{"facility":23,"status":24,"city":25,"state":26,"zip":27,"country":28,"countryCode":29,"cosmosGeoPoint":30,"geoPoint":35,"contacts":36},"MD Anderson Cancer Center","RECRUITING","Houston","Texas","77030","United States","US",{"type":31,"coordinates":32},"Point",[33,34],-95.36327,29.76328,{"lat":34,"lon":33},[37,38],{"name":14,"role":18,"phone":19,"phoneExt":7,"email":20},{"name":14,"role":15,"phone":7,"phoneExt":7,"email":7},{"type":40,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100609517","financial-toxicity-in-patients-with-resected-soft-tissue-and-bone-sarcomas-100609517",false,"NCT07215611","Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas","Inclusion Criteria:\n\n* Participants who are seen preoperatively at our institution before surgery for primary malignant bone tumor or primary malignant soft tissue tumor will be identified.\n* Adult orthopedic oncology patients. Stratified by diagnosis of primary malignant bone tumor and primary malignant soft tissue tumor.\n\nExclusion Criteria\n\n• Non-English subjects will not be recruited. Subjects are required to be able to read\u002Fwrite in English.","ALL",{"count":49,"type":50},100,"ESTIMATED","OBSERVATIONAL","To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.",[54,55],"Bone Sarcomas","Financial Toxicity","2026-04-28",{"date":58,"type":59},"2026-04-30","ACTUAL",{"date":61,"type":59},"2025-09-02",{"date":63,"type":50},"2030-10-02",{"name":5,"class":6},1]